Bosh sahifaSBHMY • OTCMKTS
add
Sino Biopharmaceutical Unsponsored Caymand Islands ADR
Yopilish kursi
9,05 $
Yillik diapazon
6,69 $ - 9,65 $
Bozor kapitalizatsiyasi
61,62 mlrd HKD
Oʻrtacha hajm
50,00
Yangiliklarda
Moliyaviy axborot
Moliyaviy hisobot
Daromad
Sof foyda
(CNY) | iyn, 2024info | Y/Y qiyosi |
---|---|---|
Daromad | 7,94 mlrd | 11,14% |
Joriy xarajat | 4,78 mlrd | 10,58% |
Sof foyda | 1,51 mlrd | 139,69% |
Sof foyda marjasi | 19,01 | 115,78% |
Har bir ulushga tushum | — | — |
EBITDA | 1,98 mlrd | 8,88% |
Amaldagi soliq stavkasi | 16,99% | — |
Balans
Jami aktivlari
Jami passivlari
(CNY) | iyn, 2024info | Y/Y qiyosi |
---|---|---|
Naqd pul va qisqa investitsiyalar | 13,18 mlrd | -15,93% |
Jami aktivlari | 66,70 mlrd | 1,62% |
Jami passivlari | 24,58 mlrd | -15,76% |
Umumiy kapital | 42,12 mlrd | — |
Tarqatilgan aksiyalar | 18,21 mlrd | — |
Narxi/balansdagi bahosi | 5,03 | — |
Aktivlardan daromad | 6,50% | — |
Kapitaldan daromad | 8,37% | — |
Pul aylanmasi
Naqd pulning sof oʻzgarishi
(CNY) | iyn, 2024info | Y/Y qiyosi |
---|---|---|
Sof foyda | 1,51 mlrd | 139,69% |
Operatsiyalardan naqd pul | 1,54 mlrd | 15,25% |
Sarmoyadan naqd pul | -1,02 mlrd | 49,91% |
Moliyadan naqd pul | -2,05 mlrd | -1,42% |
Naqd pulning sof oʻzgarishi | -1,52 mlrd | 43,37% |
Boʻsh pul | 1,09 mlrd | 36,59% |
Haqida
Sino Biopharmaceutical Limited, shortly Sino Biopharm, is a civilian-run enterprise principally engaged in the medicine products business in Mainland China.
Being a member of Charoen Pokphand Group and headquartered in Hong Kong and Beijing, Sino Biopharm is engaged in researching, developing, producing, and selling biopharmaceutical products for the medical treatment of ophthalmia, as well as modernized Chinese medicine and chemical medicine for the treatment of hepatitis through its subsidiaries.
Sino Biopharm is also involved in other minor businesses through its subsidiaries, such as properties, health food, optical glass, optical and auditory products. Wikipedia
CEO
Tashkil etilgan
2000
Sayt
Xodimlar soni
24 437